Relevant conflicts of interest/financial disclosures: Nothing to report.
Cell Therapy for Parkinson's Disease: What Next?
Article first published online: 6 FEB 2013
Copyright © 2013 Movement Disorder Society
Special Issue: The Vatican Conference on Neuroprotection in Parkinson's Disease
Volume 28, Issue 1, pages 110–115, January 2013
How to Cite
Bjorklund, A. and Kordower, J. H. (2013), Cell Therapy for Parkinson's Disease: What Next?. Mov. Disord., 28: 110–115. doi: 10.1002/mds.25343
Full financial disclosures and author roles may be found in the online version of this article.
- Issue published online: 6 FEB 2013
- Article first published online: 6 FEB 2013
- Manuscript Accepted: 13 DEC 2012
- Manuscript Revised: 11 DEC 2012
- Manuscript Received: 1 OCT 2012
This article has been cited by:
- 1A brief perspective on neural cell therapy, Molecular and Cellular Therapies, 2014, 2, 1, 2,
- 3Human Umbilical Cord Mesenchymal Stem Cells Infected with Adenovirus ExpressingHGFPromote Regeneration of Damaged Neuron Cells in a Parkinson’s Disease Model, BioMed Research International, 2014, 2014, 1, , , , , , , , , ,
- 4Stem cell therapy for the treatment of parasitic infections: is it far away?, Parasitology Research, 2014, 113, 2, 607, , , , ,
- 5Striatal cholinergic interneurons in isolated generalized dystoniaâ€”rationale and perspectives for stem cell-derived cellular models, Frontiers in Cellular Neuroscience, 2014, 8,, , , ,
- 7Differentiation of hUC-MSC into dopaminergic-like cells after transduction with hepatocyte growth factor, Molecular and Cellular Biochemistry, 2013, 381, 1-2, 183, , , , , , , ,
- 8Enhanced dopamine release by mesenchymal stem cells reprogrammed neuronally by the modulators of SMAD signaling, chromatin modifying enzymes, and cyclic adenosine monophosphate levels, Translational Research, 2013, 162, 5, 317, ,